Clinical Trial Update: An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and effectiveness of BMS-986165 with background treatment in lupus nephritis; study terminated with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• BMS-986165

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lupus Nephritis | Phase 2 | Status: TERMINATED | Results posted: 2022-10-17